HEAL TECHNOLOGY
LIVE

Serial Number

97871705

Owner

Acandis GmbH

Attorney

Kathryn A. Gromlovits

Filing Date

Apr 4, 2023

Add to watchlist:

No watchlists yet
View on USPTO

HEAL TECHNOLOGY Trademark

Serial Number: 97871705 • Registration: 7575527

HEAL TECHNOLOGY is a trademark filed by Acandis GmbH on April 4, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Acandis GmbH (31 trademarks)

Theodor-Fahrner-Str. 6

Entity Type: 99

Trademark Details

Filing Date

April 4, 2023

Registration Date

November 26, 2024

Published for Opposition

September 24, 2024

Goods & Services

Pharmaceutical preparations for the treatment of strokes and neurovascular disorders; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of neurological disorders, in particular neurological disorders affecting the central nervous system, the peripheral nervous system and the autonomic nervous system; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of brain injury, in particular stroke, brain trauma and global ischemia; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of neurodegenerative disorders; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of stroke and dementia in particular, Alzheimer's disease, Parkinson's disease, senile dementia and Huntington's disease; Pharmaceutical preparations and additives in the nature of dietary supplements for neuroprotection in particular for treatment and alleviation of symptoms of strokes; Medical instruments and apparatus, namely, delivery apparatus for fibrin sealant and fibrin scaffold; Bio-functional antithrombogenic and endothelialisation coatings, namely, drug delivery agents in the form of a coating for stents that facilitate the delivery of a wide range of pharmaceuticals for treatment of neurovascular diseases; Biological skin tissue intended for subsequent implantation; Tissues for surgical use being surgical implants comprised of living tissues; Pharmaceutical preparations in liquid form for the treatment of neurological and neurovascular disorders; pharmaceutical preparations, namely, liquid embolic agents

Surgical and medical apparatus for use in treating stroke and blockage or inflammation of cerebral vessels; surgical devices and instruments; Medical stents in the nature of surgical implant made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; Grafts being surgical implants made of artificial materials; Flow diverters, namely, surgical implants comprised of artificial materials; Medical guidewires and medical filters being blood filters, for use in the fields of Radiology, Cardiology and Neurology for the treatment of strokes and neurovascular disorders; Surgical and medical instruments, namely, stent-retrievers and stents for blood and blood components for medical purposes for use in the radiology, cardiology and neurology sectors, in particular for treating strokes and neurovascular disorders; Medical recanalisation devices for use in treating blood clots; Medical embolisation devices for use in treating hemoptysis; Medical application systems for surgical and medical apparatus, devices and instruments, in particular catheters; Medical devices, namely, pulse generators used with a neurostimulation system for neurostimulation; Prosthetic tissues for vascular use; Medical electrodes for the simulation of nerve paths; Medical electrodes for the treatment of epilepsy and Alzheimer's disease

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 26, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 26, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 24, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 4, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 14, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 30, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 30, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 30, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 27, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 8, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 8, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 8, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 30, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 28, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2023 NWOS
NEW APPLICATION ENTERED
Apr 7, 2023 NWAP